FEBS Letters
Volume 583, Issue 1 , Pages 61-69, 5 January 2009

Regulation of growth and survival of activated T cells by cell-transducing inhibitors of Ras

Edited by Lukas Huber

  • Nasser M. Malik

      Affiliations

    • Biochemical Pharmacology, William Harvey Research Institute, Queen Mary’s School of Medicine and Dentistry, Charterhouse Square, London EC1M 6BQ, United Kingdom
    • Present address: Kennedy Institute of Rheumatology, Imperial College, 1 Aspenlea Road, London W6 8LH, United Kingdom.
  • ,
  • Derek W. Gilroy

      Affiliations

    • Centre for Clinical Pharmacology, Department of Medicine, Rayne Institute, University College London, 5 University Street, London WC1 6JJ, United Kingdom
  • ,
  • Panagiotis S. Kabouridis

      Affiliations

    • Biochemical Pharmacology, William Harvey Research Institute, Queen Mary’s School of Medicine and Dentistry, Charterhouse Square, London EC1M 6BQ, United Kingdom
    • Corresponding Author InformationCorresponding author. Fax: +44 (0) 20 7882 6076.

Received 8 September 2008; received in revised form 17 November 2008; accepted 27 November 2008. published online 08 December 2008.

Abstract 

We describe the development of cell-penetrating inhibitors of Ras and study their ability to inhibit T cell activation. The inhibitors transduced T cells in a time and concentration-dependent manner and interacted with endogenous Ras. Anti-CD3/CD28-activated cells when treated with the inhibitors, exhibited a notable reduction in cell size, diminished proliferative capacity, and were more prone to apoptosis. Similarly, lymphocytes activated by antigen in vivo, exhibited accelerated apoptosis when treated with the inhibitors ex vivo. Our data reveal a pro-survival role for Ras in activated primary T cells and describe a new methodology for regulating its activity.

Structured summary

MINT-6802882: RAF1 (uniprotkb:P04049) physically interacts (MI:0218) with RAS (uniprotkb:P01112) by anti tag co-immunoprecipitation (MI:0007)

Abbreviations: RBD, Ras-binding domain of Raf-1, PTD, protein transduction domain, TCR, T cell antigen receptor, mBSA, methylated BSA, DTH, delayed type hypersensitivity

Keywords: Ras, Signalling inhibitor, Protein transduction domain, T cell activation, Apoptosis, T cell antigen receptor

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S0014-5793(08)00969-1

doi:10.1016/j.febslet.2008.11.042

FEBS Letters
Volume 583, Issue 1 , Pages 61-69, 5 January 2009